TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | -4 | 6 | 63 | 135 | 12 | 35 |
| P | %wins | 0 | 0 | 100 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/24/14 10:05 | 12/22/14 | SNGX | Soligenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Warusz Joseph Michael | NJ | O | VP of Fi | P.d | 10 | 1.21 | 0 | 8 | 176 | 13 | D | 76 | -43 | -52 | -49 | -46 | -33 | -27 | -24 | -1 | -4 | 6 | 63 | 135 | 12 |
5/19/14 07:30 | 5/19/14 | SNGX | Soligenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Warusz Joseph Michael | NJ | O | VP of Ad | M.d | 3 | 0.6400 | 0 | 5 | New | 5 | D | 497 | 54 | -12 | -4 | -6 | -2 | 6 | -1 | -2 | -9 | 6 | 2 | -11 | -26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |